| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ying Liang, Xin Y. The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study. Neuropsychiatric disease and treatment. vol 13. 2020-10-01. PMID:28461752. |
the effectiveness and safety of amisulpride in chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the escape study. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ying Liang, Xin Y. The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study. Neuropsychiatric disease and treatment. vol 13. 2020-10-01. PMID:28461752. |
this subgroup analysis of the escape study evaluated the efficacy and safety of amisulpride in chinese patients with schizophrenia who switched from risperidone or olanzapine. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ying Liang, Xin Y. Effectiveness of amisulpride in Chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the ESCAPE study. Neuropsychiatric disease and treatment. vol 13. 2020-10-01. PMID:28721051. |
effectiveness of amisulpride in chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the escape study. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ying Liang, Xin Y. Effectiveness of amisulpride in Chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the ESCAPE study. Neuropsychiatric disease and treatment. vol 13. 2020-10-01. PMID:28721051. |
therefore, we investigated amisulpride for the treatment of chinese patients with predominantly negative symptoms of schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Thomas R E Barnes, Verity Leeson, Carol Paton, Louise Marston, David P Osborn, Raj Kumar, Patrick Keown, Rameez Zafar, Khalid Iqbal, Vineet Singh, Pavel Fridrich, Zachary Fitzgerald, Hemant Bagalkote, Peter M Haddad, Mariwan Husni, Tim Amo. Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial. Therapeutic advances in psychopharmacology. vol 8. issue 7. 2020-10-01. PMID:29977519. |
amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial. |
2020-10-01 |
2023-08-13 |
Not clear |
| Jeong Ha Park, Ji Son Hong, Sun Mi Kim, Kyung Joon Min, Un Sun Chung, Doug Hyun Ha. Effects of Amisulpride Adjunctive Therapy on Working Memory and Brain Metabolism in the Frontal Cortex of Patients with Schizophrenia: A Preliminary Positron Emission Tomography/Computerized Tomography Investigation. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 17. issue 2. 2020-10-01. PMID:30905125. |
effects of amisulpride adjunctive therapy on working memory and brain metabolism in the frontal cortex of patients with schizophrenia: a preliminary positron emission tomography/computerized tomography investigation. |
2020-10-01 |
2023-08-13 |
Not clear |
| Jeong Ha Park, Ji Son Hong, Sun Mi Kim, Kyung Joon Min, Un Sun Chung, Doug Hyun Ha. Effects of Amisulpride Adjunctive Therapy on Working Memory and Brain Metabolism in the Frontal Cortex of Patients with Schizophrenia: A Preliminary Positron Emission Tomography/Computerized Tomography Investigation. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 17. issue 2. 2020-10-01. PMID:30905125. |
additionally, treatment of patients with schizophrenia using amisulpride, a pure dopamine class 2/3 receptor antagonist, improves their clinical symptoms with fewer side effects. |
2020-10-01 |
2023-08-13 |
Not clear |
| Jeong Ha Park, Ji Son Hong, Sun Mi Kim, Kyung Joon Min, Un Sun Chung, Doug Hyun Ha. Effects of Amisulpride Adjunctive Therapy on Working Memory and Brain Metabolism in the Frontal Cortex of Patients with Schizophrenia: A Preliminary Positron Emission Tomography/Computerized Tomography Investigation. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 17. issue 2. 2020-10-01. PMID:30905125. |
we hypothesized that patients with schizophrenia treated with amisulpride and aripiprazole show increased working memory and glucose metabolism compared with those treated with cognitive behavioral therapy (cbt) and aripiprazole instead. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ping Yang, Liang Li, Dong Yang, Chaoying Wang, Hongli Peng, Huiyong Huang, Xuejun Li. Effect of Peony-Glycyrrhiza Decoction on Amisulpride-Induced Hyperprolactinemia in Women with Schizophrenia: A Preliminary Study. Evidence-based complementary and alternative medicine : eCAM. vol 2017. 2020-09-30. PMID:29317896. |
the aim of this study is to observe the effect of peony-glycyrrhiza decoction (pgd) on hyperprolactinemia in women with schizophrenia induced by amisulpride. |
2020-09-30 |
2023-08-13 |
Not clear |
| Bo Fang, Hong M. Ventricular Arrhythmia during Tracheal Intubation and Extubation under General Anesthesia Possibly Induced by Amisulpride: A Case Report. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 16. issue 3. 2020-09-30. PMID:30121989. |
we are presenting the first documented case of amisulpride related ventricular arrhythmia during tracheal intubation and extubation under general anesthesia in an 48 year-old female with psychiatric history of chronic schizophrenia who was treated with amisulpride. |
2020-09-30 |
2023-08-13 |
Not clear |
| Ali Abdall-Razak, Alex Macaulay, Jakov Tiefenbach, Karen Borges, Sina Mathema, Sameer Zuber. A cost-utility analysis of Amisulpride and Paliperidone in the treatment of Schizophrenia. Heliyon. vol 5. issue 9. 2020-09-29. PMID:31687534. |
a cost-utility analysis of amisulpride and paliperidone in the treatment of schizophrenia. |
2020-09-29 |
2023-08-13 |
Not clear |
| Ali Abdall-Razak, Alex Macaulay, Jakov Tiefenbach, Karen Borges, Sina Mathema, Sameer Zuber. A cost-utility analysis of Amisulpride and Paliperidone in the treatment of Schizophrenia. Heliyon. vol 5. issue 9. 2020-09-29. PMID:31687534. |
amisulpride and paliperidone are two antipsychotics used to treat schizophrenia in the uk. |
2020-09-29 |
2023-08-13 |
Not clear |
| Xavier Boland, Preeti Chhabr. Dramatic Weight Loss Following Addition of Aripiprazole to Olanzapine in a Patient With Treatment-resistant Schizophrenia: A Case Report. Journal of psychiatric practice. vol 25. issue 2. 2020-06-19. PMID:30849062. |
a 26-year-old man with a history of longstanding treatment-resistant schizophrenia gained a substantial amount of weight while being treated with high-dose combination antipsychotic therapy with olanzapine and amisulpride. |
2020-06-19 |
2023-08-13 |
Not clear |
| Kasper Jessen, Egill Rostrup, Rene C W Mandl, Mette Ø Nielsen, Nikolaj Bak, Birgitte Fagerlund, Birte Y Glenthøj, Bjørn H Ebdru. Cortical structures and their clinical correlates in antipsychotic-naïve schizophrenia patients before and after 6 weeks of dopamine D2/3 receptor antagonist treatment. Psychological medicine. vol 49. issue 5. 2020-05-14. PMID:29734953. |
in antipsychotic-naïve schizophrenia patients, we investigated cortical thickness and surface area as well as mean curvature before and after monotherapy with amisulpride, a relatively selective dopamine d2/3 receptor antagonist. |
2020-05-14 |
2023-08-13 |
Not clear |
| Davide Martino, Vikram Karnik, Sydney Osland, Thomas R E Barnes, Tamara M Pringshei. Movement Disorders Associated With Antipsychotic Medication in People With Schizophrenia: An Overview of Cochrane Reviews and Meta-Analysis. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 2020-02-25. PMID:29758999. |
we conducted meta-analyses of randomised controlled trials included in the cochrane database of systematic reviews on schizophrenia and schizophrenia-like psychoses to estimate the prevalence of new-onset dystonia, akathisia, parkinsonism, and tremor with sgas (amisulpride, asenapine, aripiprazole, clozapine, olanzapine, paliperidone, quetiapine, risperidone, l-sulpiride, and ziprasidone) approved in canada and the uk, comparing them with haloperidol and chlorpromazine. |
2020-02-25 |
2023-08-13 |
Not clear |
| Padraig Wright, Luke O'Flahert. Antipsychotic drugs: atypical advantages and typical disadvantages. Irish journal of psychological medicine. vol 20. issue 1. 2019-11-20. PMID:30440229. |
the atypical antipsychotic drugs currently marketed in ireland for the first line treatment of schizophrenia include amisulpride, olanzapine, quetiapine, risperidone and ziprasidone. |
2019-11-20 |
2023-08-13 |
Not clear |
| Guru S Gowda, Leela Shanker Sastry Nagavarapu, Shiva Shanker Reddy Mukku, Syed Farooq Al. Amisulpride Induced Oropharyngeal Dyskinesia in a patient with Schizophrenia: A case report and review of literature. Asian journal of psychiatry. vol 41. 2019-08-13. PMID:29146045. |
amisulpride induced oropharyngeal dyskinesia in a patient with schizophrenia: a case report and review of literature. |
2019-08-13 |
2023-08-13 |
Not clear |
| René S Kahn, Inge Winter van Rossum, Stefan Leucht, Philip McGuire, Shon W Lewis, Marion Leboyer, Celso Arango, Paola Dazzan, Richard Drake, Stephan Heres, Covadonga M Díaz-Caneja, Dan Rujescu, Mark Weiser, Silvana Galderisi, Birte Glenthøj, Marinus J C Eijkemans, W Wolfgang Fleischhacker, Shitij Kapur, Iris E Somme. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study. The lancet. Psychiatry. vol 5. issue 10. 2019-08-09. PMID:30115598. |
amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (optimise): a three-phase switching study. |
2019-08-09 |
2023-08-13 |
Not clear |
| Peng Men, Zhanmiao Yi, Chaoyun Li, Shuli Qu, Tengbin Xiong, Xin Yu, Suodi Zha. Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis. BMC psychiatry. vol 18. issue 1. 2019-07-10. PMID:30185173. |
comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in china: a systematic review, meta-analysis, and cost-minimization analysis. |
2019-07-10 |
2023-08-13 |
Not clear |
| Peng Men, Zhanmiao Yi, Chaoyun Li, Shuli Qu, Tengbin Xiong, Xin Yu, Suodi Zha. Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis. BMC psychiatry. vol 18. issue 1. 2019-07-10. PMID:30185173. |
amisulpride was introduced into china in 2010 as a second-generation atypical antipsychotic, while olanzapine has been on the market since 1999 as one of the leading treatments for schizophrenia in china. |
2019-07-10 |
2023-08-13 |
Not clear |